Key Takeaway Anti-IL-33 biologics represent a promising new frontier for refractory COPD, especially for patients with low type 2 inflammation who do not respond to existing treatments. Phase III data…
Key Takeaway Anti-IL-33 biologics represent a promising new frontier for refractory COPD, especially for patients with low type 2 inflammation who do not respond to existing treatments. Phase III data…
Small airways are the quiet workhorses of the lung. They contribute little to total airway resistance in health, so they can deteriorate for years without making a sound. By the time spirometry shows …
Picture this: a patient with moderate asthma walks into your clinic for a routine checkup. Their spirometry looks fine. Their symptom diary is clean. But inside their blood, a specific ratio of sphing…
Your patient breathes out, and within seconds, a sensor detects molecular signals of a developing lung infection. No blood draw. No radiation. No waiting days for culture results. This is not a futuri…
When a patient with central airway obstruction (CAO) arrives in the emergency department, every second counts. The trachea or main bronchi are narrowed by tumor, scar tissue, or a foreign body. Breath…
Extracorporeal membrane oxygenation has come a long way from its origins as a last-resort salvage therapy. For critical care physicians, perfusionists, and respiratory therapists managing severe respi…
Intensivists and respiratory therapists know the challenge well. You are managing a patient with Acute Respiratory Distress Syndrome, and every ventilator adjustment feels like a trade off. Push too h…